
Alexandre Sepriano
@alexsepriano
Rheumatologist MD PhD | 2019-2020 Chair of @EMEUNET | 2023-2025 Leader young @Official_ASAS | Interests: SpA/RA diagnosis/outcomes, epidemiology, biostatistics
ID: 879783545622982656
27-06-2017 19:28:37
1,1K Tweet
1,1K Followers
684 Following



✅Portuguese Recommendations for the Management of Raynaud’s Phenomenon and Digital Ulcers in SSc and other CTDs #raynaud #ulcerasdigitais #digitalulcers #esclerosesistemica #scleroderma #CPR2024 Rúben Duarte Fernandes vitor teixeira Vasco C Romao Alexandre Sepriano ARP Rheumatology


Access the full recommendations here: arprheumatology.com/section.php?id… Daniela Faria Alessia Alunno Lovro Lamot EUSTAR EMEUNET Ana Maria Rodrigues Pedro Machado Global Scleroderma Initiative @scleroderma SRUK | Scleroderma & Raynaud's UK MOScleroderma Scleroderma Canada Scleroderma EULAR HPR - Health Professionals in Rheumatology EULAR








Diving into the new year with a must-attend session at the ASAS Core Course! Join us for Prof. Denis Poddubnyy drpoddubnyy Hot Topic presentation on 'What is and What to Do About Difficult to Manage axSpA.' #SpA #Rheumatology #ASASCoreCourse #HotTopic








New from the Slide Library: ASAS publication from Alexandre Sepriano et al Higher ASDAS was longitudinally associated with higher spinal radiographic progression in patients with r-axSpA independently of treatment with TNFi. 👉 pubmed.ncbi.nlm.nih.gov/33118014/

